Chk1 inhibition potentiates the therapeutic efficacy of PARP inhibitor BMN673 in gastric cancer.
Yin Y, Shen Q, Zhang P, Tao R, Chang W, Li R, Xie G, Liu W, Zhang L, Kapoor P, Song S, Ajani J, Mills GB, Chen J, Tao K, Peng G.
Yin Y, et al.
Am J Cancer Res. 2017 Mar 1;7(3):473-483. eCollection 2017.
Am J Cancer Res. 2017.
PMID: 28401005
Free PMC article.